Shuttle Pharmaceuticals Holdings, Inc.
SHPH· Nasdaq
Released Sep 3, 2024, after the close
10-Q filed Sep 4, 2024, 66 days after period end · 0001493152-24-034902
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$2.03M | -$2.18M | -$597.28K | -$346.80K |
| EPS Diluted | -$24.12 | -$1.23 | -$0.06 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Shuttle Pharmaceuticals Holdings, Inc. · CIK 1757499 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2024 · filed Sep 4, 2024 · 66 d after period end
+12.9% from the close of Sep 3, 2024 to the close of Sep 4, 2024, the first after the release.